J MATTHEW SINGLETON

CIK 1243514 · last filed 2026-01-05

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$363.7K

Companies

3

Total Filings

34

Lifetime Open-Market Net

-$6.82M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
VKTX Director 12,650 $28.75 $363.7K -$4.58M 12 2026-01-05
Viking Therapeutics, Inc. (VKTXW) Delisted Director 9,500 $4.60 $43.7K $93.3K 6 2021-01-06
CUBIST PHARMACEUTICALS INC (CBST) Delisted Director 4,972 -$2.34M 16 2013-06-14

Recent Filings · Page 4 of 4

34 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2008-11-20 CUBIST PHARMACEUTICALS INC (CBST) Delisted Mixed -$21.8K EDGAR
2008-10-30 CUBIST PHARMACEUTICALS INC (CBST) Delisted Mixed -$19.4K EDGAR
2008-06-12 CUBIST PHARMACEUTICALS INC (CBST) Delisted Grant (A) $0 EDGAR
2007-06-08 CUBIST PHARMACEUTICALS INC (CBST) Delisted Grant (A) $0 EDGAR
Showing 3134 of 34
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.